O	0	10	Definition	Definition	NN	B-NP
O	11	13	of	of	IN	B-PP
O	14	23	pathogens	pathogen	NNS	B-NP

O	24	26	It	It	PRP	B-NP
O	27	34	remains	remain	VBZ	B-VP
O	35	44	difficult	difficult	JJ	B-ADJP
O	45	47	to	to	TO	B-VP
O	48	57	determine	determine	VB	I-VP
O	58	65	whether	whether	IN	B-SBAR
O	66	69	the	the	DT	B-NP
O	70	79	organisms	organism	NNS	I-NP
O	80	88	detected	detect	VBN	B-VP
O	89	91	by	by	IN	B-PP
O	92	95	the	the	DT	B-NP
O	96	99	DNA	DNA	NN	I-NP
O	100	109	Detection	Detection	NN	I-NP
O	110	113	Kit	Kit	NN	I-NP
O	114	117	are	be	VBP	B-VP
O	118	122	true	true	JJ	B-NP
O	123	132	pathogens	pathogen	NNS	I-NP
O	132	133	.	.	.	O

O	134	138	This	This	DT	B-NP
O	139	143	also	also	RB	B-ADVP
O	144	151	applies	apply	VBZ	B-VP
O	151	152	,	,	,	O
O	153	161	although	although	IN	B-SBAR
O	162	164	to	to	TO	B-PP
O	165	166	a	a	DT	B-NP
O	167	171	much	much	RB	I-NP
O	172	178	lesser	less	JJR	I-NP
O	179	185	degree	degree	NN	I-NP
O	185	186	,	,	,	O
O	187	189	to	to	TO	B-PP
O	190	202	conventional	conventional	JJ	B-NP
B-Organism_substance	203	208	blood	blood	NN	I-NP
O	209	216	culture	culture	NN	I-NP
O	217	225	analysis	analysis	NN	I-NP
O	225	226	.	.	.	O

O	227	234	However	However	RB	B-ADVP
O	234	235	,	,	,	O
O	236	244	detected	detect	VBN	B-NP
O	245	254	organisms	organism	NNS	I-NP
O	255	259	were	be	VBD	B-VP
O	260	270	considered	consider	VBN	I-VP
O	271	273	to	to	TO	I-VP
O	274	276	be	be	VB	I-VP
O	277	286	pathogens	pathogen	NNS	B-NP
O	287	289	if	if	IN	B-SBAR
O	290	293	the	the	DT	B-NP
O	294	301	results	result	NNS	I-NP
O	302	304	of	of	IN	B-PP
O	305	312	culture	culture	NN	B-NP
O	313	318	tests	test	NNS	I-NP
O	319	323	from	from	IN	B-PP
B-Organism_substance	324	331	samples	sample	NNS	B-NP
O	332	334	of	of	IN	B-PP
O	335	338	the	the	DT	B-NP
O	339	348	suspected	suspect	VBN	I-NP
O	349	359	infectious	infectious	JJ	I-NP
O	360	365	sites	site	NNS	I-NP
O	366	375	coincided	coincide	VBN	B-VP
O	376	380	with	with	IN	B-PP
O	381	384	the	the	DT	B-NP
O	385	392	results	result	NNS	I-NP
O	393	395	of	of	IN	B-PP
O	396	399	DNA	DNA	NN	B-NP
O	400	409	Detection	Detection	NN	I-NP
O	410	413	Kit	Kit	NN	I-NP
O	414	416	or	or	CC	O
B-Organism_substance	417	422	blood	blood	NN	B-NP
O	423	430	culture	culture	NN	I-NP
O	431	439	analysis	analysis	NN	I-NP
O	439	440	.	.	.	O

O	441	444	The	The	DT	B-NP
O	445	452	culture	culture	NN	I-NP
O	453	457	data	datum	NNS	I-NP
O	458	460	of	of	IN	B-PP
B-Organism_substance	461	467	sputum	sputum	NN	B-NP
O	467	468	,	,	,	O
B-Organism_substance	469	474	urine	urine	NN	B-NP
O	474	475	,	,	,	O
B-Organism_substance	476	479	pus	pus	NN	B-NP
O	480	483	and	and	CC	O
O	484	492	drainage	drainage	NN	B-NP
B-Organism_substance	493	498	fluid	fluid	NN	I-NP
O	499	503	were	be	VBD	B-VP
O	504	508	used	use	VBN	I-VP
O	509	511	to	to	TO	B-VP
O	512	518	define	define	VB	I-VP
O	519	522	the	the	DT	B-NP
O	523	532	pathogens	pathogen	NNS	I-NP
O	532	533	.	.	.	O

O	534	535	A	A	DT	B-NP
O	536	544	decision	decision	NN	I-NP
O	545	547	as	as	IN	B-PP
O	548	550	to	to	TO	B-PP
O	551	558	whether	whether	IN	B-SBAR
O	559	561	an	an	DT	B-NP
O	562	572	identified	identify	VBN	I-NP
O	573	581	organism	organism	NN	I-NP
O	582	585	was	be	VBD	B-VP
O	586	587	a	a	DT	B-NP
O	588	596	pathogen	pathogen	NN	I-NP
O	597	600	was	be	VBD	B-VP
O	601	606	taken	take	VBN	I-VP
O	607	612	based	base	VBN	B-PP
O	613	615	on	on	IN	B-PP
O	616	619	the	the	DT	B-NP
O	620	628	decision	decision	NN	I-NP
O	629	633	tree	tree	NN	I-NP
O	634	639	shown	show	VBN	B-VP
O	640	642	in	in	IN	B-PP
O	643	649	Figure	Figure	NN	B-NP
O	650	651	1	1	CD	I-NP
O	651	652	.	.	.	O

O	653	657	Thus	Thus	RB	B-ADVP
O	657	658	,	,	,	O
O	659	663	when	when	WRB	B-ADVP
O	664	667	the	the	DT	B-NP
O	668	672	same	same	JJ	I-NP
O	673	681	organism	organism	NN	I-NP
O	682	685	was	be	VBD	B-VP
O	686	694	detected	detect	VBN	I-VP
O	695	697	by	by	IN	B-PP
O	698	702	both	both	CC	O
O	703	706	DNA	DNA	NN	B-NP
O	707	716	Detection	Detection	NN	I-NP
O	717	720	Kit	Kit	NN	I-NP
O	721	724	and	and	CC	O
B-Organism_substance	725	730	blood	blood	NN	B-NP
O	731	738	culture	culture	NN	I-NP
O	739	747	analysis	analysis	NN	I-NP
O	747	748	,	,	,	O
O	749	752	the	the	DT	B-NP
O	753	761	detected	detect	VBN	I-NP
O	762	770	organism	organism	NN	I-NP
O	771	774	was	be	VBD	B-VP
O	775	785	considered	consider	VBN	I-VP
O	786	788	an	an	DT	B-NP
O	789	799	infectious	infectious	JJ	I-NP
O	800	808	pathogen	pathogen	NN	I-NP
O	808	809	.	.	.	O

O	810	812	If	If	IN	B-SBAR
O	813	818	there	there	EX	B-NP
O	819	822	was	be	VBD	B-VP
O	823	824	a	a	DT	B-NP
O	825	836	discrepancy	discrepancy	NN	I-NP
O	837	844	between	between	IN	B-PP
O	845	848	the	the	DT	B-NP
O	849	857	organism	organism	NN	I-NP
O	858	862	that	that	WDT	B-NP
O	863	866	was	be	VBD	B-VP
O	867	875	detected	detect	VBN	I-VP
O	876	878	by	by	IN	B-PP
O	879	888	SeptiFast	SeptiFast	JJ	B-NP
O	889	897	analysis	analysis	NN	I-NP
O	898	901	and	and	CC	O
O	902	906	that	that	DT	B-NP
O	907	915	detected	detect	VBN	B-VP
O	916	918	by	by	IN	B-PP
B-Organism_substance	919	924	blood	blood	NN	B-NP
O	925	932	culture	culture	NN	I-NP
O	933	941	analysis	analysis	NN	I-NP
O	941	942	,	,	,	O
O	943	945	or	or	CC	O
O	946	948	if	if	IN	B-SBAR
O	949	951	an	an	DT	B-NP
O	952	960	organism	organism	NN	I-NP
O	961	964	was	be	VBD	B-VP
O	965	969	only	only	RB	I-VP
O	970	978	detected	detect	VBN	I-VP
O	979	981	in	in	IN	B-PP
O	982	985	one	one	CD	B-NP
O	986	988	of	of	IN	B-PP
O	989	994	these	these	DT	B-NP
O	995	1000	tests	test	NNS	I-NP
O	1000	1001	,	,	,	O
O	1002	1006	then	then	RB	O
O	1007	1012	other	other	JJ	B-NP
B-Organism_substance	1013	1020	samples	sample	NNS	I-NP
O	1021	1026	taken	take	VBN	B-VP
O	1027	1031	from	from	IN	B-PP
O	1032	1035	the	the	DT	B-NP
O	1036	1045	infection	infection	NN	I-NP
O	1046	1050	site	site	NN	I-NP
O	1051	1055	were	be	VBD	B-VP
O	1056	1064	analyzed	analyze	VBN	I-VP
O	1064	1065	.	.	.	O

O	1066	1068	If	If	IN	B-SBAR
O	1069	1073	this	this	DT	B-NP
O	1074	1080	second	second	JJ	I-NP
O	1081	1088	culture	culture	NN	I-NP
O	1089	1093	test	test	NN	I-NP
O	1094	1096	of	of	IN	B-PP
O	1097	1100	the	the	DT	B-NP
O	1101	1110	suspected	suspect	VBN	I-NP
O	1111	1121	infectious	infectious	JJ	I-NP
O	1122	1126	site	site	NN	I-NP
O	1127	1135	revealed	reveal	VBD	B-VP
O	1136	1139	the	the	DT	B-NP
O	1140	1148	presence	presence	NN	I-NP
O	1149	1151	of	of	IN	B-PP
O	1152	1155	the	the	DT	B-NP
O	1156	1160	same	same	JJ	I-NP
O	1161	1169	organism	organism	NN	I-NP
O	1169	1170	,	,	,	O
O	1171	1175	this	this	DT	B-NP
O	1176	1184	organism	organism	NN	I-NP
O	1185	1188	was	be	VBD	B-VP
O	1189	1199	considered	consider	VBN	I-VP
O	1200	1202	to	to	TO	I-VP
O	1203	1205	be	be	VB	I-VP
O	1206	1207	a	a	DT	B-NP
O	1208	1216	pathogen	pathogen	NN	I-NP
O	1216	1217	.	.	.	O

O	1218	1220	If	If	IN	B-SBAR
O	1221	1224	the	the	DT	B-NP
O	1225	1234	microbial	microbial	JJ	I-NP
B-Cell	1235	1241	strain	strain	NN	I-NP
O	1242	1245	was	be	VBD	B-VP
O	1246	1250	only	only	RB	I-VP
O	1251	1259	detected	detect	VBN	I-VP
O	1260	1264	once	once	RB	B-ADVP
O	1265	1268	for	for	IN	B-PP
O	1269	1270	a	a	DT	B-NP
B-Organism_substance	1271	1277	sample	sample	NN	I-NP
O	1277	1278	,	,	,	O
O	1279	1281	we	we	PRP	B-NP
O	1282	1286	then	then	RB	B-ADVP
O	1287	1294	checked	check	VBD	B-VP
O	1295	1298	the	the	DT	B-NP
O	1299	1305	second	second	JJ	I-NP
O	1306	1313	culture	culture	NN	I-NP
O	1314	1321	results	result	VBZ	B-VP
O	1322	1324	in	in	IN	B-PP
O	1325	1328	the	the	DT	B-NP
O	1329	1338	suspected	suspect	VBN	I-NP
O	1339	1349	infectious	infectious	JJ	I-NP
O	1350	1355	sites	site	NNS	I-NP
O	1355	1356	.	.	.	O

O	1357	1359	If	If	IN	B-SBAR
O	1360	1364	this	this	DT	B-NP
O	1365	1371	result	result	NN	I-NP
O	1372	1382	identified	identify	VBD	B-VP
O	1383	1386	the	the	DT	B-NP
O	1387	1391	same	same	JJ	I-NP
B-Cell	1392	1398	strain	strain	NN	I-NP
O	1399	1401	as	as	IN	B-PP
O	1402	1406	that	that	DT	B-NP
O	1407	1417	identified	identify	VBN	B-VP
O	1418	1420	by	by	IN	B-PP
O	1421	1430	SeptiFast	SeptiFast	JJ	B-NP
O	1431	1439	analysis	analysis	NN	I-NP
O	1440	1444	then	then	RB	B-ADVP
O	1445	1447	it	it	PRP	B-NP
O	1448	1451	was	be	VBD	B-VP
O	1452	1459	decided	decide	VBN	I-VP
O	1460	1464	that	that	IN	B-SBAR
O	1465	1469	this	this	DT	B-NP
B-Cell	1470	1476	strain	strain	NN	I-NP
O	1477	1480	was	be	VBD	B-VP
O	1481	1482	a	a	DT	B-NP
O	1483	1491	pathogen	pathogen	NN	I-NP
O	1491	1492	.	.	.	O

O	1493	1500	However	However	RB	B-ADVP
O	1500	1501	,	,	,	O
O	1502	1504	if	if	IN	B-SBAR
O	1505	1508	the	the	DT	B-NP
B-Cell	1509	1515	strain	strain	NN	I-NP
O	1516	1519	was	be	VBD	B-VP
O	1520	1525	still	still	RB	I-VP
O	1526	1530	only	only	RB	I-VP
O	1531	1539	detected	detect	VBN	I-VP
O	1540	1542	in	in	IN	B-PP
O	1543	1547	some	some	DT	B-NP
O	1548	1550	of	of	IN	B-PP
O	1551	1554	the	the	DT	B-NP
O	1555	1561	assays	assay	NNS	I-NP
O	1561	1562	,	,	,	O
O	1563	1565	we	we	PRP	B-NP
O	1566	1570	next	next	RB	B-ADVP
O	1571	1581	determined	determine	VBD	B-VP
O	1582	1584	if	if	IN	B-SBAR
O	1585	1588	the	the	DT	B-NP
O	1589	1596	patient	patient	NN	I-NP
O	1597	1605	involved	involve	VBN	B-VP
O	1606	1614	suffered	suffer	VBD	B-VP
O	1615	1619	from	from	IN	B-PP
O	1620	1626	sepsis	sepsis	NN	B-NP
O	1626	1627	.	.	.	O

O	1628	1634	Sepsis	Sepsis	NN	B-NP
O	1635	1637	is	be	VBZ	B-VP
O	1638	1645	defined	define	VBN	I-VP
O	1646	1648	as	as	IN	B-PP
O	1649	1653	SIRS	SIRS	NNS	B-NP
O	1654	1660	caused	cause	VBN	B-VP
O	1661	1663	by	by	IN	B-PP
O	1664	1673	infection	infection	NN	B-NP
O	1673	1674	.	.	.	O

O	1675	1678	The	The	DT	B-NP
O	1679	1689	definition	definition	NN	I-NP
O	1690	1692	of	of	IN	B-PP
O	1693	1699	sepsis	sepsis	NN	B-NP
O	1700	1704	that	that	IN	B-NP
O	1705	1707	we	we	PRP	B-NP
O	1708	1712	used	use	VBD	B-VP
O	1713	1716	was	be	VBD	B-VP
O	1717	1722	based	base	VBN	I-VP
O	1723	1725	on	on	IN	B-PP
O	1726	1729	the	the	DT	B-NP
O	1730	1743	International	International	NNP	I-NP
O	1744	1750	Sepsis	Sepsis	NNP	I-NP
O	1751	1756	Forum	Forum	NNP	I-NP
O	1757	1767	Definition	Definition	NNP	I-NP
O	1768	1770	of	of	IN	B-PP
O	1771	1780	Infection	Infection	NNP	B-NP
O	1781	1783	at	at	IN	B-PP
O	1784	1787	the	the	DT	B-NP
O	1788	1791	ICU	ICU	NNP	I-NP
O	1792	1801	Consensus	Consensus	NNP	I-NP
O	1802	1812	Conference	Conference	NNP	I-NP
O	1813	1814	[	[	(	O
O	1814	1815	7	7	CD	B-NP
O	1815	1816	]	]	)	O
O	1816	1817	.	.	.	O

O	1818	1825	However	However	RB	B-ADVP
O	1825	1826	,	,	,	O
O	1827	1829	if	if	IN	B-SBAR
O	1830	1833	the	the	DT	B-NP
O	1834	1844	underlying	underlie	VBG	I-NP
O	1845	1852	disease	disease	NN	I-NP
O	1853	1855	is	be	VBZ	B-VP
B-Cancer	1856	1861	acute	acute	JJ	B-NP
I-Cancer	1862	1870	lymphoma	lymphoma	NN	I-NP
I-Cancer	1871	1879	leukemia	leukemia	NN	I-NP
O	1880	1881	(	(	(	O
B-Cancer	1881	1884	ALL	ALL	NN	B-NP
O	1884	1885	)	)	)	O
O	1885	1886	,	,	,	O
B-Cancer	1887	1896	malignant	malignant	JJ	B-NP
I-Cancer	1897	1905	lymphoma	lymphoma	NN	I-NP
O	1906	1907	(	(	(	O
B-Cancer	1907	1909	ML	ML	NN	B-NP
O	1909	1910	)	)	)	O
O	1910	1911	,	,	,	O
O	1912	1914	or	or	CC	O
B-Cancer	1915	1920	acute	acute	JJ	B-NP
I-Cancer	1921	1932	myelogenous	myelogenous	JJ	I-NP
I-Cancer	1933	1941	leukemia	leukemia	NN	I-NP
O	1942	1943	(	(	(	O
B-Cancer	1943	1946	AML	AML	NN	B-NP
O	1946	1947	)	)	)	O
O	1947	1948	,	,	,	O
O	1949	1952	the	the	DT	B-NP
O	1953	1963	definition	definition	NN	I-NP
O	1964	1966	of	of	IN	B-PP
O	1967	1976	infection	infection	NN	B-NP
O	1977	1979	is	be	VBZ	B-VP
O	1980	1987	defined	define	VBN	I-VP
O	1988	1990	as	as	IN	B-PP
O	1991	1994	the	the	DT	B-NP
O	1995	2002	ability	ability	NN	I-NP
O	2003	2005	to	to	TO	B-VP
O	2006	2012	detect	detect	VB	I-VP
O	2013	2023	infectious	infectious	JJ	B-NP
O	2024	2033	organisms	organism	NNS	I-NP
O	2034	2036	by	by	IN	B-PP
B-Organism_substance	2037	2042	blood	blood	NN	B-NP
O	2043	2050	culture	culture	NN	I-NP
O	2051	2059	analysis	analysis	NN	I-NP
O	2059	2060	.	.	.	O

O	2061	2063	If	If	IN	B-SBAR
O	2064	2067	the	the	DT	B-NP
O	2068	2075	patient	patient	NN	I-NP
O	2076	2079	was	be	VBD	B-VP
O	2080	2083	not	not	RB	I-VP
O	2084	2091	defined	define	VBN	I-VP
O	2092	2094	as	as	IN	B-PP
O	2095	2101	having	have	VBG	B-VP
O	2102	2108	sepsis	sepsis	NN	B-NP
O	2109	2113	when	when	WRB	B-ADVP
B-Organism_substance	2114	2119	whole	whole	JJ	B-NP
I-Organism_substance	2120	2125	blood	blood	NN	I-NP
O	2126	2129	was	be	VBD	B-VP
O	2130	2142	administered	administer	VBN	I-VP
O	2143	2145	to	to	TO	B-PP
O	2146	2149	the	the	DT	B-NP
O	2150	2157	patient	patient	NN	I-NP
O	2157	2158	,	,	,	O
O	2159	2161	we	we	PRP	B-NP
O	2162	2169	decided	decide	VBD	B-VP
O	2170	2174	that	that	IN	B-SBAR
O	2175	2178	the	the	DT	B-NP
B-Cell	2179	2185	strain	strain	NN	I-NP
O	2186	2194	detected	detect	VBN	B-VP
O	2195	2197	by	by	IN	B-PP
O	2198	2208	subsequent	subsequent	JJ	B-NP
O	2209	2212	DNA	DNA	NN	I-NP
O	2213	2222	Detection	Detection	NN	I-NP
O	2223	2226	Kit	Kit	NN	I-NP
O	2227	2229	or	or	CC	O
B-Organism_substance	2230	2235	blood	blood	NN	B-NP
O	2236	2243	culture	culture	NN	I-NP
O	2244	2252	analysis	analysis	NN	I-NP
O	2253	2256	was	be	VBD	B-VP
O	2257	2260	not	not	RB	O
O	2261	2262	a	a	DT	B-NP
O	2263	2271	pathogen	pathogen	NN	I-NP
O	2271	2272	.	.	.	O

O	2273	2279	Figure	Figure	NN	B-NP
O	2280	2281	1	1	CD	I-NP

O	2282	2291	Flowchart	Flowchart	NN	B-NP
O	2292	2295	for	for	IN	B-PP
O	2296	2304	pathogen	pathogen	NN	B-NP
O	2305	2313	decision	decision	NN	I-NP
O	2313	2314	.	.	.	O

B-Organism_substance	2315	2322	Samples	Sample	NNS	B-NP
O	2323	2327	were	be	VBD	B-VP
O	2328	2335	defined	define	VBN	I-VP
O	2336	2338	as	as	IN	B-PP
O	2339	2347	negative	negative	JJ	B-ADJP
O	2348	2351	for	for	IN	B-PP
O	2352	2361	pathogens	pathogen	NNS	B-NP
O	2362	2364	if	if	IN	B-SBAR
O	2365	2366	a	a	DT	B-NP
O	2367	2375	pathogen	pathogen	NN	I-NP
O	2376	2381	could	could	MD	B-VP
O	2382	2385	not	not	RB	I-VP
O	2386	2388	be	be	VB	I-VP
O	2389	2397	detected	detect	VBN	I-VP
O	2398	2400	by	by	IN	B-PP
O	2401	2404	any	any	DT	B-NP
O	2405	2411	method	method	NN	I-NP
O	2412	2414	of	of	IN	B-PP
O	2415	2423	analysis	analysis	NN	B-NP
O	2424	2430	within	within	IN	B-PP
O	2431	2436	seven	seven	CD	B-NP
O	2437	2441	days	day	NNS	I-NP
O	2441	2442	,	,	,	O
O	2443	2446	and	and	CC	O
O	2447	2449	if	if	IN	B-SBAR
O	2450	2457	another	another	DT	B-NP
O	2458	2462	type	type	NN	I-NP
O	2463	2465	of	of	IN	B-PP
O	2466	2473	culture	culture	NN	B-NP
O	2474	2478	test	test	NN	I-NP
O	2479	2482	did	do	VBD	B-VP
O	2483	2486	not	not	RB	I-VP
O	2487	2493	detect	detect	VB	I-VP
O	2494	2498	this	this	DT	B-NP
O	2499	2507	pathogen	pathogen	NN	I-NP
O	2508	2511	but	but	CC	O
O	2512	2517	could	could	MD	B-VP
O	2518	2524	detect	detect	VB	I-VP
O	2525	2530	other	other	JJ	B-NP
O	2531	2540	organisms	organism	NNS	I-NP
O	2540	2541	.	.	.	O

O	2542	2546	CoNS	CoNS	NN	B-NP
O	2547	2555	bacteria	bacteria	NNS	I-NP
O	2555	2556	,	,	,	O
O	2557	2562	which	which	WDT	B-NP
O	2563	2566	are	be	VBP	B-VP
O	2567	2578	represented	represent	VBN	I-VP
O	2579	2581	by	by	IN	B-PP
O	2582	2585	the	the	DT	B-NP
O	2586	2600	Staphylococcus	Staphylococcus	NN	I-NP
O	2601	2612	epidermidis	epidermidis	NN	I-NP
O	2613	2614	(	(	(	O
O	2614	2615	S	S	NN	B-NP
O	2615	2616	.	.	.	O
O	2617	2628	epidermidis	epidermidis	''	O
O	2628	2629	)	)	)	O
O	2630	2633	and	and	CC	O
O	2634	2647	Streptococcus	Streptococcus	NN	B-NP
O	2648	2651	spp	spp	NN	I-NP
O	2651	2652	.	.	.	O
O	2653	2656	are	be	VBP	B-VP
O	2657	2667	indigenous	indigenous	JJ	B-NP
O	2668	2676	bacteria	bacteria	NNS	I-NP
O	2677	2680	and	and	CC	O
O	2681	2686	often	often	RB	B-VP
O	2687	2692	cause	cause	VBP	I-VP
O	2693	2706	contamination	contamination	NN	B-NP
O	2707	2709	in	in	IN	B-PP
O	2710	2716	assays	assay	NNS	B-NP
O	2717	2719	of	of	IN	B-PP
O	2720	2729	pathogens	pathogen	NNS	B-NP
O	2729	2730	.	.	.	O

O	2731	2740	Therefore	Therefore	RB	B-ADVP
O	2740	2741	,	,	,	O
O	2742	2746	when	when	WRB	B-ADVP
O	2747	2751	CoNS	CoNS	NN	B-NP
O	2752	2754	or	or	CC	O
O	2755	2768	Streptococcus	Streptococcus	NNP	B-NP
O	2769	2772	spp	spp	NN	I-NP
O	2772	2773	.	.	.	O
O	2774	2778	were	be	VBD	B-VP
O	2779	2787	detected	detect	VBN	I-VP
O	2788	2790	by	by	IN	B-PP
B-Organism_substance	2791	2796	blood	blood	NN	B-NP
O	2797	2804	culture	culture	NN	I-NP
O	2805	2808	and	and	CC	O
O	2809	2818	SeptiFast	SeptiFast	JJ	B-NP
O	2819	2827	analysis	analysis	NN	I-NP
O	2827	2828	,	,	,	O
O	2829	2832	the	the	DT	B-NP
O	2833	2842	following	follow	VBG	I-NP
O	2843	2851	criteria	criterion	NNS	I-NP
O	2852	2856	were	be	VBD	B-VP
O	2857	2864	applied	apply	VBN	I-VP
O	2865	2867	to	to	TO	I-VP
O	2868	2874	define	define	VB	I-VP
O	2875	2882	whether	whether	IN	B-SBAR
O	2883	2888	these	these	DT	B-NP
B-Cell	2889	2896	strains	strain	NNS	I-NP
O	2897	2908	represented	represent	VBD	B-VP
O	2909	2910	a	a	DT	B-NP
O	2911	2921	pathogenic	pathogenic	JJ	I-NP
O	2922	2931	infection	infection	NN	I-NP
O	2931	2932	:	:	:	O
O	2933	2934	(	(	(	B-LST
O	2934	2935	1	1	LS	I-LST
O	2935	2936	)	)	)	O
O	2937	2942	Tests	Test	NNPS	B-NP
O	2943	2947	were	be	VBD	B-VP
O	2948	2957	performed	perform	VBN	I-VP
O	2958	2960	at	at	IN	B-ADVP
O	2961	2966	least	least	JJS	I-ADVP
O	2967	2972	twice	twice	RB	B-ADVP
O	2973	2979	within	within	IN	B-PP
O	2980	2982	48	48	CD	B-NP
O	2983	2988	hours	hour	NNS	I-NP
O	2989	2995	before	before	IN	B-PP
O	2996	2999	and	and	CC	I-PP
O	3000	3005	after	after	IN	I-PP
O	3006	3010	CoNS	CoNS	NN	B-NP
O	3011	3015	were	be	VBD	B-VP
O	3016	3024	detected	detect	VBN	I-VP
O	3025	3027	by	by	IN	B-PP
B-Organism_substance	3028	3033	blood	blood	NN	B-NP
O	3034	3041	culture	culture	NN	I-NP
O	3042	3044	or	or	CC	O
O	3045	3054	SeptiFast	SeptiFast	JJ	B-NP
O	3055	3063	analysis	analysis	NN	I-NP
O	3063	3064	;	;	:	O
O	3065	3066	(	(	(	B-LST
O	3066	3067	2	2	LS	I-LST
O	3067	3068	)	)	)	O
O	3069	3073	CoNS	CoNS	NNPS	B-NP
O	3074	3076	or	or	CC	O
O	3077	3090	Streptococcus	Streptococcus	NNP	B-NP
O	3091	3094	spp	spp	NN	I-NP
O	3094	3095	.	.	.	O
O	3096	3100	were	be	VBD	B-VP
O	3101	3109	detected	detect	VBN	I-VP
O	3110	3112	in	in	IN	B-PP
O	3113	3116	two	two	CD	B-NP
O	3117	3126	different	different	JJ	I-NP
B-Organism_substance	3127	3132	blood	blood	NN	I-NP
O	3133	3140	culture	culture	NN	I-NP
O	3141	3146	tests	test	NNS	I-NP
O	3147	3151	that	that	WDT	B-NP
O	3152	3156	were	be	VBD	B-VP
O	3157	3167	separately	separately	RB	I-VP
O	3168	3177	performed	perform	VBN	I-VP
O	3178	3183	twice	twice	RB	B-ADVP
O	3184	3190	within	within	IN	B-PP
O	3191	3193	48	48	CD	B-NP
O	3194	3199	hours	hour	NNS	I-NP
O	3199	3200	;	;	:	O
O	3201	3204	and	and	CC	O
O	3204	3205	,	,	,	O
O	3206	3207	(	(	(	B-LST
O	3207	3208	3	3	LS	I-LST
O	3208	3209	)	)	)	O
O	3210	3214	CoNS	CoNS	NN	B-NP
O	3215	3217	or	or	CC	O
O	3218	3231	Streptococcus	Streptococcus	NNP	B-NP
O	3232	3235	spp	spp	NN	I-NP
O	3235	3236	.	.	.	O
O	3237	3241	were	be	VBD	B-VP
O	3242	3250	detected	detect	VBN	I-VP
O	3251	3256	twice	twice	RB	B-NP
O	3257	3259	or	or	CC	I-NP
O	3260	3264	more	more	JJR	I-NP
O	3265	3267	in	in	IN	B-PP
O	3268	3273	tests	test	NNS	B-NP
O	3274	3278	that	that	WDT	B-NP
O	3279	3283	were	be	VBD	B-VP
O	3284	3293	performed	perform	VBN	I-VP
O	3294	3299	three	three	CD	B-NP
O	3300	3305	times	time	NNS	I-NP
O	3306	3307	[	[	(	O
O	3307	3309	11	11	CD	B-NP
O	3309	3310	-	-	HYPH	I-NP
O	3310	3312	15	15	CD	I-NP
O	3312	3313	]	]	)	O
O	3313	3314	.	.	.	O

O	3315	3317	If	If	IN	B-SBAR
O	3318	3319	a	a	DT	B-NP
B-Organism_substance	3320	3326	sample	sample	NN	I-NP
O	3326	3327	'	'	POS	B-NP
O	3327	3328	s	s	NN	I-NP
O	3329	3336	results	result	NNS	I-NP
O	3337	3340	met	meet	VBD	B-VP
O	3341	3344	any	any	DT	B-NP
O	3345	3347	of	of	IN	B-PP
O	3348	3353	these	these	DT	B-NP
O	3354	3359	three	three	CD	I-NP
O	3360	3368	criteria	criterion	NNS	I-NP
O	3368	3369	,	,	,	O
O	3370	3374	then	then	RB	B-ADVP
O	3375	3378	the	the	DT	B-NP
B-Organism_substance	3379	3385	sample	sample	NN	I-NP
O	3386	3389	was	be	VBD	B-VP
O	3390	3399	evaluated	evaluate	VBN	I-VP
O	3400	3402	as	as	IN	B-PP
O	3403	3404	a	a	DT	B-NP
O	3405	3413	pathogen	pathogen	NN	I-NP
O	3413	3414	.	.	.	O

O	3415	3418	The	The	DT	B-NP
O	3419	3430	distinction	distinction	NN	I-NP
O	3431	3438	between	between	IN	B-PP
O	3439	3447	pathogen	pathogen	NN	B-NP
O	3448	3451	and	and	CC	I-NP
O	3452	3465	contamination	contamination	NN	I-NP
O	3466	3469	was	be	VBD	B-VP
O	3470	3474	also	also	RB	I-VP
O	3475	3485	determined	determine	VBN	I-VP
O	3486	3489	for	for	IN	B-PP
O	3490	3494	CoNS	CoNS	NN	B-NP
O	3495	3497	or	or	CC	O
O	3498	3511	Streptococcus	Streptococcus	NNP	B-NP
O	3512	3515	spp	spp	NN	I-NP
O	3515	3516	.	.	.	O
O	3517	3521	from	from	IN	B-PP
O	3522	3525	the	the	DT	B-NP
O	3526	3534	crossing	cross	VBG	I-NP
O	3535	3540	point	point	NN	I-NP
O	3541	3542	(	(	(	O
O	3542	3544	Cp	Cp	NN	B-NP
O	3544	3545	)	)	)	O
O	3546	3554	obtained	obtain	VBN	B-VP
O	3555	3560	using	use	VBG	B-VP
O	3561	3564	the	the	DT	B-NP
O	3565	3576	LightCycler	LightCycler	NNP	I-NP
O	3577	3585	analysis	analysis	NN	I-NP
O	3586	3594	software	software	NN	I-NP
O	3595	3597	v4	v4	NN	I-NP
O	3597	3598	.	.	.	O
O	3598	3600	05	05	CD	B-NP
O	3600	3601	.	.	.	O

O	3602	3605	The	The	DT	B-NP
O	3606	3608	Cp	Cp	NN	I-NP
O	3609	3619	represents	represent	VBZ	B-VP
O	3620	3623	the	the	DT	B-NP
O	3624	3629	point	point	NN	I-NP
O	3630	3632	in	in	IN	B-PP
O	3633	3636	the	the	DT	B-NP
O	3637	3650	amplification	amplification	NN	I-NP
O	3651	3656	cycle	cycle	NN	I-NP
O	3657	3662	where	where	WRB	B-ADVP
O	3663	3666	the	the	DT	B-NP
O	3667	3680	amplification	amplification	NN	I-NP
O	3681	3686	curve	curve	NN	I-NP
O	3687	3694	crosses	cross	VBZ	B-VP
O	3695	3698	the	the	DT	B-NP
O	3699	3708	detection	detection	NN	I-NP
O	3709	3718	threshold	threshold	NN	I-NP
O	3718	3719	.	.	.	O

O	3720	3724	When	When	WRB	B-ADVP
O	3725	3729	CoNS	CoNS	NN	B-NP
O	3730	3732	or	or	CC	O
O	3733	3746	Streptococcus	Streptococcus	NNP	B-NP
O	3747	3750	spp	spp	NN	I-NP
O	3750	3751	.	.	.	O
O	3752	3756	were	be	VBD	B-VP
O	3757	3765	detected	detect	VBN	I-VP
O	3766	3771	using	use	VBG	B-VP
O	3772	3775	the	the	DT	B-NP
O	3776	3787	LightCycler	LightCycler	NNP	I-NP
O	3788	3796	analysis	analysis	NN	I-NP
O	3797	3805	software	software	NN	I-NP
O	3806	3808	v4	v4	NN	I-NP
O	3808	3809	.	.	.	O
O	3809	3811	05	05	CD	B-NP
O	3811	3812	,	,	,	O
O	3813	3814	a	a	DT	B-NP
O	3815	3817	Cp	Cp	NN	I-NP
O	3818	3820	of	of	IN	B-PP
O	3821	3825	less	less	JJR	B-NP
O	3826	3830	than	than	IN	I-NP
O	3831	3833	20	20	CD	I-NP
O	3834	3837	was	be	VBD	B-VP
O	3838	3845	defined	define	VBN	I-VP
O	3846	3848	as	as	IN	B-PP
O	3849	3859	indicating	indicate	VBG	B-VP
O	3860	3861	a	a	DT	B-NP
O	3862	3870	pathogen	pathogen	NN	I-NP
O	3871	3874	and	and	CC	O
O	3875	3876	a	a	DT	B-NP
O	3877	3879	Cp	Cp	NN	I-NP
O	3880	3882	of	of	IN	B-PP
O	3883	3887	over	over	IN	B-NP
O	3888	3890	20	20	CD	I-NP
O	3891	3894	was	be	VBD	B-VP
O	3895	3902	defined	define	VBN	I-VP
O	3903	3905	as	as	IN	B-PP
O	3906	3919	contamination	contamination	NN	B-NP
O	3920	3922	by	by	IN	B-PP
O	3923	3931	checking	check	VBG	B-VP
O	3932	3935	the	the	DT	B-NP
O	3936	3949	amplification	amplification	NN	I-NP
O	3950	3955	curve	curve	NN	I-NP
O	3955	3956	.	.	.	O

